- Home
- SLF vs IQV Comparison
SLF vs IQV Comparison
Compare SLF & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLF
- IQV
- Stock Information
- Founded
- SLF 1871
- IQV 1982
- Country
- SLF Canada
- IQV United States
- Employees
- SLF N/A
- IQV N/A
- Industry
- SLF Advertising
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SLF Consumer Discretionary
- IQV Health Care
- Exchange
- SLF Nasdaq
- IQV Nasdaq
- Market Cap
- SLF 33.2B
- IQV 31.0B
- IPO Year
- SLF N/A
- IQV 2013
- Fundamental
- Price
- SLF $60.31
- IQV $206.57
- Analyst Decision
- SLF Buy
- IQV Strong Buy
- Analyst Count
- SLF 1
- IQV 20
- Target Price
- SLF $88.00
- IQV $229.15
- AVG Volume (30 Days)
- SLF 426.0K
- IQV 1.3M
- Earning Date
- SLF 11-03-2025
- IQV 10-28-2025
- Dividend Yield
- SLF 4.08%
- IQV N/A
- EPS Growth
- SLF 6.78
- IQV N/A
- EPS
- SLF 4.13
- IQV 6.92
- Revenue
- SLF $25,028,961,904.00
- IQV $15,700,000,000.00
- Revenue This Year
- SLF N/A
- IQV $6.00
- Revenue Next Year
- SLF $3.09
- IQV $4.98
- P/E Ratio
- SLF $14.28
- IQV $29.85
- Revenue Growth
- SLF 6.85
- IQV 3.60
- 52 Week Low
- SLF $52.44
- IQV $134.65
- 52 Week High
- SLF $66.81
- IQV $237.34
- Technical
- Relative Strength Index (RSI)
- SLF 58.97
- IQV 69.00
- Support Level
- SLF $58.66
- IQV $176.16
- Resistance Level
- SLF $60.36
- IQV $189.62
- Average True Range (ATR)
- SLF 0.72
- IQV 5.75
- MACD
- SLF 0.15
- IQV 2.28
- Stochastic Oscillator
- SLF 90.62
- IQV 92.02
About SLF Sun Life Financial Inc.
Sun Life Financial is one of the Big Three Canadian life insurers. The Canadian business contributed around 38% of adjusted earnings. In that segment, the firm provides health, life insurance, and annuity products to individual and group customers. Its US business is mostly group health and contributed about 20% of the firm's adjusted earnings in 2024. Sun Life also offers life insurance and wealth products in several Asian markets with a strong presence in Hong Kong and the Philippines. The Asia segment contributed around 18% of adjusted 2024 earnings. Its asset management business had around CAD 1.1 trillion total assets under management or administration at the end of 2024 and represents around 34% of the firm's earnings.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.